Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trialsColin Baigent, Faı̈ez Zannad, David Preiss et al.|The Lancet|2022Cited by 969
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney FunctionFaı̈ez Zannad, Milton Packer, João Pedro Ferreira et al.|Circulation|2020Cited by 276
Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob MiceThomas Albrecht, Sibylle J. Hauske|Scientific Reports|2017Cited by 127
Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized MacrophagesHui Li, Sibylle J. Hauske|International Journal of Molecular Sciences|2023Cited by 10